Skip to Main Content

Paper Details

Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells.
Sci Rep
6
2020
Autoimmunity, EAE, FGIN-1-27, Pathogenic, TSPO, Th17 Cells, Th17 cell, Th17 cells, amino acid, autoimmune diseases, autoimmune disorders, autoimmune encephalomyelitis, autoimmunity, fatty acid, translocator protein
Author NameAffiliation
Ajit JadhavDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Noel SouthallDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Noel SouthallDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Marc FerrerDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
  • 1 - 4

Datasets

Release 1.2